Regulation of Interleukin-1α Expression by Integrins and Epidermal Growth Factor Receptor in Keratinocytes from a Mouse Model of Inflammatory Skin Disease*

Transgenic mice expressing β1 integrins in the suprabasal epidermal layers have sporadic skin hyperproliferation and inflammation correlated with activation of extracellular signal-regulated kinase (Erk) mitogen-activated protein kinase and increased interleukin (IL)-1α production. We investigated the link between aberrant integrin expression, Erk activation, and expression of IL-1α. Transgenic keratinocytes had higher basal Erk activity and IL-1α levels than nontransgenic controls and were more sensitive to stimulation of Erk activity and IL-1α production by IL-1α, 12-O-tetradecanoylphorbol-13-acetate (TPA), epidermal growth factor (EGF), and serum. Inhibition of Erk in transgenic keratinocytes reduced basal IL-1α levels and the stimulation of IL-1α production by serum or phorbol ester, demonstrating that Erk could regulate IL-1α expression. TPA or IL-1α treatment resulted in rapid down-regulation of the EGF receptor in transgenic cells, indicative of transactivation. Inhibition of transactivation blocked basal and TPA or IL-1α induced Erk activation, but not IκBα degradation, and abolished increased IL-1α production in transgenic cells. In transgene-negative cells, constitutive activation of IL-1-dependent signaling by wild type or kinase-dead IRAK1 stimulated IL-1α production independent of Erk. We conclude that suprabasal integrin expression leads to Erk activation and increased IL-1α expression by potentiating activation of the EGF receptor. These results provide a mechanism by which aberrant integrin expression triggers epidermal hyperproliferation and inflammation.

[1]  C. Tacchetti,et al.  Integrin-induced Epidermal Growth Factor (EGF) Receptor Activation Requires c-Src and p130Cas and Leads to Phosphorylation of Specific EGF Receptor Tyrosines* , 2002, The Journal of Biological Chemistry.

[2]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[3]  W. Parks,et al.  Keratinocyte Collagenase-1 Expression Requires an Epidermal Growth Factor Receptor Autocrine Mechanism* , 1999, The Journal of Biological Chemistry.

[4]  M. Feldmann,et al.  Modulation of the IL‐1 cytokine network in keratinocytes by intracellular IL‐1α and IL‐1 receptor antagonist , 1995, Clinical and experimental immunology.

[5]  V. Mamidipudi,et al.  Identification of Interleukin 1 Receptor-associated Kinase as a Conserved Component in the p75-Neurotrophin Receptor Activation of Nuclear Factor-κB* , 2002, The Journal of Biological Chemistry.

[6]  S. Wasserman,et al.  Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. , 1999, Journal of immunology.

[7]  F. Watt,et al.  Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis , 1995, Cell.

[8]  Z. Werb,et al.  Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. , 1998, Science.

[9]  S. Fischer,et al.  Signal transduction pathway(s) involved in phorbol ester and autocrine induction of interleukin-1 alpha mRNA in murine keratinocytes. , 1994, The Journal of biological chemistry.

[10]  M Locati,et al.  Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.

[11]  Douglas K. Miller,et al.  The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.

[12]  I. Haase,et al.  Activation of epidermal growth factor receptor/ERK signaling correlates with suppressed differentiation in malignant acanthosis nigricans. , 2002, The Journal of investigative dermatology.

[13]  G. Hunninghake,et al.  A constitutive active MEK --> ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation. , 2000, The Journal of biological chemistry.

[14]  M. Blumenberg,et al.  Interleukin-1 induces transcription of keratin K6 in human epidermal keratinocytes. , 2001, The Journal of investigative dermatology.

[15]  G. Nolan,et al.  Retroviral delivery of peptide modulators of cellular functions. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  S. Fischer,et al.  Altered expression of interleukin‐1 receptor antagonist in different stages of mouse skin carcinogenesis , 1999 .

[17]  D. Woodley,et al.  Interleukin-1α Stimulates Keratinocyte Migration Through an Epidermal Growth Factor/Transforming Growth Factor-α-Independent Pathway , 1995 .

[18]  Weiya Ma,et al.  Transactivation of the Epidermal Growth Factor Receptor Is Involved in 12-O-Tetradecanoylphorbol-13-acetate-induced Signal Transduction* , 2001, The Journal of Biological Chemistry.

[19]  J. Saurat,et al.  Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes , 1991, FEBS letters.

[20]  J. Prins,et al.  The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. , 1997, Journal of immunology.

[21]  S. Kunkel,et al.  Activation of p38, ERK1/2 and NIK Pathways is Required for IL-1β and TNF-α-induced Chemokine Expression in Human Retinal Pigment Epithelial Cells , 2001 .

[22]  G. Stark,et al.  Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.

[23]  Fiona M. Watt,et al.  The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development , 2000, Cell.

[24]  E. Unanue,et al.  Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Bastiaens,et al.  PKCα regulates β1 integrin‐dependent cell motility through association and control of integrin traffic , 1999 .

[26]  Z. Werb,et al.  Phagocytosis mediated by Yersinia invasin induces collagenase-1 expression in rabbit synovial fibroblasts through a proinflammatory cascade. , 2001, Journal of cell science.

[27]  M. Pittelkow,et al.  Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. , 1998, The Journal of investigative dermatology.

[28]  T. Mak,et al.  Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.

[29]  W. Arend.  Interleukin-1 receptor antagonist. , 1993, Advances in immunology.

[30]  G. Plowman,et al.  Amphiregulin‐dependent proliferation of cultured human keratinocytes: Autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin‐like glycosaminoglycans , 1994, Journal of cellular physiology.

[31]  J. DiGiovanni,et al.  Evidence for autocrine/paracrine growth stimulation by transforming growth factor‐α during the process of skin tumor promotion , 1991, Molecular carcinogenesis.

[32]  K. Malcolm,et al.  Cross-talk between ERK and p38 MAPK Mediates Selective Suppression of Pro-inflammatory Cytokines by Transforming Growth Factor-β* , 2002, The Journal of Biological Chemistry.

[33]  James T. Elder,et al.  Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture. , 1997, The Journal of clinical investigation.

[34]  P. Khavari,et al.  Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation , 2002, Oncogene.

[35]  M. Tomic-Canic,et al.  Keratins and the keratinocyte activation cycle. , 2001, The Journal of investigative dermatology.

[36]  L. Silengo,et al.  Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion‐dependent cell survival , 1998, The EMBO journal.

[37]  S. Dower,et al.  Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. , 1995, Journal of immunology.

[38]  F. Watt,et al.  Influence of β1 Integrins on Epidermal Squamous Cell Carcinoma Formation in a Transgenic Mouse Model α3β1, but not α2β1, Suppresses Malignant Conversion , 2001 .

[39]  M. Goebl,et al.  Modulation of Tumor Necrosis Factor and Interleukin-1-dependent NF-κB Activity by mPLK/IRAK* , 1999, The Journal of Biological Chemistry.

[40]  D. Roop,et al.  The expression and modulation of IL-1 alpha in murine keratinocytes. , 1988, Journal of immunology.

[41]  A. Rubartelli,et al.  Synthesis and Secretion of Interleukin-1α and Intedeukin-1 Receptor Antagonist during Differentiation of Cultured Keratinocytes , 1995 .

[42]  F. Watt,et al.  Correlation between hyperproliferation and suprabasal integrin expression in human epidermis reconstituted in culture , 1997, Experimental dermatology.

[43]  F. Watt,et al.  Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis: effects of suprabasal integrin expression on keratinocyte adhesion, proliferation and terminal differentiation , 1999, Experimental dermatology.

[44]  A. Hall,et al.  Lipopolysaccharide-Induced Activation of β2-Integrin Function in Macrophages Requires Irak Kinase Activity, p38 Mitogen- Activated Protein Kinase, and the Rap1 GTPase , 2001, Molecular and Cellular Biology.

[45]  F. Watt,et al.  Role of integrins in regulating epidermal adhesion, growth and differentiation , 2002, The EMBO journal.

[46]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[47]  G. Stark,et al.  Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-κB p65/RelA Subunit , 1999, Molecular and Cellular Biology.

[48]  E. Mekada,et al.  Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites , 1995, The Journal of cell biology.

[49]  J. Yodoi,et al.  Redox-sensitive Transactivation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor Confers the NF-κB Activation* , 2001, The Journal of Biological Chemistry.

[50]  F. Watt,et al.  Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. , 1992, The Journal of clinical investigation.

[51]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Y. Wan,et al.  Transmodulation of epidermal growth factor receptor mediates IL-1 beta-induced MMP-1 expression in cultured human keratinocytes. , 2001, International journal of molecular medicine.

[53]  J. Abraham,et al.  Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. , 2000, Circulation research.

[54]  P. Libby,et al.  Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. , 1997, Journal of immunology.

[55]  S. Kuwada,et al.  Integrin α5/β1 Mediates Fibronectin-dependent Epithelial Cell Proliferation through Epidermal Growth Factor Receptor Activation , 2000 .

[56]  Rina Hemi,et al.  Transactivation of ErbB2 and ErbB3 by Tumor Necrosis Factor-α and Anisomycin Leads to Impaired Insulin Signaling through Serine/Threonine Phosphorylation of IRS Proteins* , 2002, The Journal of Biological Chemistry.

[57]  Fenglin Liu,et al.  Distinct Roles of the Adaptor Protein Shc and Focal Adhesion Kinase in Integrin Signaling to ERK* , 2000, The Journal of Biological Chemistry.

[58]  Crafford A. Harris,et al.  Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production , 1998, The Journal of experimental medicine.

[59]  E. Mekada,et al.  Integrin alpha 2 beta 1-dependent EGF receptor activation at cell-cell contact sites. , 2000, Journal of cell science.

[60]  F. Watt,et al.  p19ARF‐independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes , 2001, EMBO reports.

[61]  A Ciechanover,et al.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. , 1999, Molecular cell.

[62]  F. Watt,et al.  Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes , 2000, Experimental dermatology.

[63]  J. Kieffer,et al.  Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[64]  I. Uings,et al.  Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation. , 2001, The Biochemical journal.

[65]  F. Watt,et al.  Signaling via beta1 integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Bowie,et al.  Transactivation by the p65 Subunit of NF-κB in Response to Interleukin-1 (IL-1) Involves MyD88, IL-1 Receptor-Associated Kinase 1, TRAF-6, and Rac1 , 2001, Molecular and Cellular Biology.

[67]  J. Knop,et al.  Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.

[68]  M. Klagsbrun,et al.  Carboxyl‐terminal truncation of leucine76 converts heparin‐binding EGF‐like growth factor from a heparin‐enhancible to a heparin‐suppressible growth factor , 1995, Journal of cellular physiology.

[69]  R. Derynck,et al.  Induction of transforming growth factor-alpha expression in human keratinocytes by phorbol esters. , 1989, The Journal of biological chemistry.

[70]  P. Elias,et al.  Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. , 1996, The Journal of investigative dermatology.

[71]  L. Nanney,et al.  Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. , 1990, The Journal of investigative dermatology.

[72]  S. Haskill,et al.  cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Holger Wesche,et al.  IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[74]  W. Fujimoto,et al.  Differential Expression of Human Cornifin α and β in Squamous Differentiating Epithelial Tissues and Several Skin Lesions. , 1997 .

[75]  M. Gayle,et al.  Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Michael U. Martin,et al.  Effects of overexpression of IL‐1 receptor‐associated kinase on NFκB activation, IL‐2 production and stress‐activated protein kinases in the murine T cell line EL4 , 1998, European journal of immunology.

[77]  J. C. Jones,et al.  NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. , 1999, The Journal of investigative dermatology.

[78]  T. Kupper,et al.  Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. , 2000, The Journal of investigative dermatology.

[79]  Y. Yarden,et al.  Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. , 1996, The EMBO journal.

[80]  M. Klagsbrun,et al.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[81]  F. Field,et al.  Tumor Necrosis Factor-α and Interleukin-1β Inhibit Apolipoprotein B Secretion in CaCo-2 Cells via the Epidermal Growth Factor Receptor Signaling Pathway* , 2000, The Journal of Biological Chemistry.